Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe Business Insights, March 2006, Pages: 178   Description     Table of Contents     Companies Mentioned        Enquire before Buying    Send to a Friend   The generics sector has grown at a fast pace over the past few years, outperforming the pharmaceutical market as a whole; generic growth opportunities are significant, with an estimated $100bn worth of branded pharmaceutical products to go off patent by 2010, of which $21bn expire in 2006. Although US and major European generic drug sales increased rapidly from 2000 to 2003, there has been a slowdown in growth during 2004. In response to an increasingly competitive unbranded generic pharmaceutical marketplace, and a slowdown in growth in 2004, some of the major generics players have consolidated. The two largest M&A deals in the generics market in recent years have been the acquisition of Eon and HEXAL Labs by Sandoz in February 2005, and the acquisition of IVAX by Teva in January 2006. “The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe” identifies the successful strategies utilized by the industry’s key players in the US and Western European market. The report provides insights into the top 10 generic companies strengths, weaknesses, opportunities and threats in the generic pharmaceutical market, allowing you to tailor the best practice strategies of the generic industry’s leading players to your company’s needs. Customers who bought this item also bought Sandoz - PharmaVitae Generics Profile Pharmavitae Generics - Teva Mylan: PharmaVitae Generics Profile Sandoz Generics Company Intelligence Report Generic Handbook: A Guide to the Generic Drug Industry in the US, 2007 Edition GenericHandbook - A Guide to the Generic Drug Industry in the US The Top 10 Generic Pharmaceutical Companies: Positioning, Performance and SWOT Analyses The World Generic Market Report 2008 Emerging Generic Drug Markets in Europe Injectable Generic Drugs: Prospects & Opportunities to 2013 Cardiovascular Generic Drugs: Prospects and Opportunities to 2012 Generic Series: An Introduction To The Canadian Generics Market - Key Trends And Leading Companies Shaping The Market

		Top of page

All rights reserved. � Copyright 2009 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster